In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 5th, 2008 | 27 | No |
Popular Name: Zopiclone Zopiclone
Find On: PubMed — Wikipedia — Google
CAS Numbers: 138729-47-2 , 138729-47-2, 43200-80-2 , 43200-80-2 , [138729-47-2] , [43200-80-2]
(+-)-zopiclone;Zopiclona [INN-Spanish];Zopiclone [Ban:Inn:Jan];Zopiclonum [INN-Latin]
138729-47-2; D02624; Estorra (TN); Eszopiclone (JAN/USAN/INN); Lunesta (TN)
43200-80-2; Amoban (TN); D01372; Zopiclone (JAN/INN); Zopiclone (TN)
Aventis Pharma brand of zopiclone
CPD000550478; Eszopiclone; SAM002548982
ct-Arzneimittel brand of zopiclone
Italfarmaco brand of zopiclone
neuraxpharm brand of zopiclone
Rhodiapharm brand of zopiclone
Rhone-Poulenc Rorer brand of zopiclone
zopiclona; zopiclone; zopiclonum
Zopiclone, Imovane, Zimovane, Lunesta
[6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.37 | 3.34 | -16.14 | 0 | 9 | 0 | 92 | 388.815 | 3 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 177 | TCI |
ALOGPS_SOLUBILITY | 8.85e-01 g/l | DrugBank-approved |
Purity | 97% | Fluorochem |
biological_use | Anticonvulsant | IBScreen Bioactives |
Indications | antiinsomnia, hypnotic | KeyOrganics Bioactives |
Therapy | hypnotic, sedative | SMDC Pharmakon |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Enamine; NCC_SUPPLIER_STRUCTURE_ID : 140614176 | NIH Clinical Collection via PubChem |
biological_use | Psychosedative | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Enamine; SUPPLIER_STRUCTURE_ID: 140614176 | NIH Clinical Collection via PubChem |
biological_use | Sedative | IBScreen Bioactives IBScreen Bioactives |
mechanism | The mechanism of action of zopiclone is similar to benzodiazepines, with similar effects on locomotor activity and on dopamine and serotonin turnover | IBScreen Bioactives |
biological_use | Tranquilizer | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GBRA1-1-E | GABA Receptor Alpha-1 Subunit (cluster #1 Of 8), Eukaryotic | Eukaryotes | 50 | 0.38 | Binding ≤ 10μM |
GBRA2-1-E | GABA Receptor Alpha-2 Subunit (cluster #1 Of 8), Eukaryotic | Eukaryotes | 114 | 0.36 | Binding ≤ 10μM |
GBRA3-1-E | GABA Receptor Alpha-3 Subunit (cluster #1 Of 8), Eukaryotic | Eukaryotes | 162 | 0.35 | Binding ≤ 10μM |
GBRA4-1-E | GABA Receptor Alpha-4 Subunit (cluster #1 Of 7), Eukaryotic | Eukaryotes | 102 | 0.36 | Binding ≤ 10μM |
Z104301-1-O | GABA-A Receptor; Anion Channel (cluster #1 Of 8), Other | Other | 29 | 0.39 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GBRA1_HUMAN | P14867 | GABA Receptor Alpha-1 Subunit, Human | 50.1 | 0.38 | Binding ≤ 1μM |
GBRA2_HUMAN | P47869 | GABA Receptor Alpha-2 Subunit, Human | 114 | 0.36 | Binding ≤ 1μM |
GBRA3_HUMAN | P34903 | GABA Receptor Alpha-3 Subunit, Human | 162 | 0.35 | Binding ≤ 1μM |
GBRA4_HUMAN | P48169 | GABA Receptor Alpha-4 Subunit, Human | 102 | 0.36 | Binding ≤ 1μM |
Z104301 | Z104301 | GABA-A Receptor; Anion Channel | 29 | 0.39 | Binding ≤ 1μM |
GBRA1_HUMAN | P14867 | GABA Receptor Alpha-1 Subunit, Human | 50.1 | 0.38 | Binding ≤ 10μM |
GBRA2_HUMAN | P47869 | GABA Receptor Alpha-2 Subunit, Human | 114 | 0.36 | Binding ≤ 10μM |
GBRA3_HUMAN | P34903 | GABA Receptor Alpha-3 Subunit, Human | 162 | 0.35 | Binding ≤ 10μM |
GBRA4_HUMAN | P48169 | GABA Receptor Alpha-4 Subunit, Human | 102 | 0.36 | Binding ≤ 10μM |
Z104301 | Z104301 | GABA-A Receptor; Anion Channel | 29 | 0.39 | Binding ≤ 10μM |
Description | Species |
---|---|
GABA A receptor activation | |
Ligand-gated ion channel transport |